A platform for sharing immunology data and research findings.
Official title: THE IMMUNOLOGY DATABASE AND ANALYSIS PORTAL (IMMPORT)
NIH-10934886 · Data updated 2026-11-12
This study is working on a user-friendly online platform called ImmPort that shares important data to help researchers better understand and treat immune system conditions, so patients can benefit from new insights and improved treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project start | September 30, 2022 |
| Project end | September 29, 2027 |
| Funding year | 2023 |
| Award (this year) | $822,770 |
| NIH project number | 316201200036W-P00003-759302200001-3 |
| Project ID | NIH-10934886 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals affected by immunological disorders or those who have experienced COVID-19.
✕Less likely to help
Patients with conditions unrelated to immunology or COVID-19 may not receive direct benefits from this research.
What this research studies
This research focuses on creating a publicly accessible data sharing platform called ImmPort, which supports immunology research and clinical studies. It provides curated datasets that follow the FAIR Principles, ensuring they are findable, accessible, interoperable, and reusable. The platform includes specific datasets like the 10K Immunomes Project and a COVID-19 compendium, which are designed to facilitate advanced research and analysis. Patients can benefit from the insights gained through this data, which can lead to improved understanding and treatment of immunological conditions.
Why it matters
Potential benefit: If successful, this research could enhance the understanding of immunological responses and improve treatment strategies for various conditions, including COVID-19.
How similar studies have gone: Other research initiatives utilizing data sharing platforms have shown success in advancing medical knowledge and treatment options, indicating a promising approach.
Where this research is happening
Dulles, United States
Researchers
- Principal investigator: Butte, Atul
- Study coordinator: Butte, Atul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.